Press release
GLP-1 Nutritional Support Market to Skyrocket to USD 13 Billion by 2035, Driven by Metabolic Health Revolution
The global GLP-1 nutritional support market is poised for explosive growth, projected to reach a staggering USD 13 billion by 2035, surging from an estimated USD 4.1 billion in 2025. This remarkable expansion is anticipated at a robust Compound Annual Growth Rate (CAGR) of 12.2% over the forecast period, reflecting a pivotal shift in addressing the comprehensive needs of individuals utilizing GLP-1 medications for weight management and metabolic health.Click Here for More Information:- https://www.futuremarketinsights.com/reports/sustained-release-excipients-market
Market Dynamics: Addressing Obesity, Diabetes, and Side Effects
The significant expansion of the GLP-1 nutritional support market is intrinsically linked to the escalating global prevalence of obesity and type 2 diabetes, which affects over 30% of the worldwide population. As GLP-1 medications like semaglutide and tirzepatide gain widespread adoption, there's a critical and increasing need for specialized nutritional support to mitigate common side effects, such as muscle loss (affecting over 40% of users) and digestive discomfort, while simultaneously enhancing overall therapeutic outcomes. Clinical treatment protocols are increasingly integrating nutritional interventions, and broader reimbursement policies for weight loss and metabolic support are further fueling market demand. Formulators are strategically shifting towards condition-specific blends that aid glycemic control, muscle preservation, and digestive balance. Ready-to-drink formats are gaining traction in major hospitals, and meal replacement kits are being covered by insurance-backed outpatient programs, often bundled with prescribed GLP-1 therapies for long-term dietary management. Despite these drivers, challenges persist, including the high cost of GLP-1 medications (averaging USD 1,200 per month) and insufficient guidance on dietary support from healthcare providers (reported by 60% of patients), which can limit broader accessibility and treatment efficacy.
Segmental Leadership: Protein Blends, Powders, and Prescription Channels Dominate
In terms of product type, Protein & Macronutrient Blends are set to dominate, projected to reach a 43% share in 2025, up from 39.4% in 2024. This growth reflects the strong integration of GLP-1 therapy with structured nutritional interventions, with 67.5% of physician-recommended nutrition plans for GLP-1 users now including protein-based formulations. Companies like Abbott (Glucerna), Nestlé Health Science (OPTIFAST), and Orgain are leading this segment. Regarding dosage forms, powders maintain their leading position, forecast to reach 38% in 2025 (from 34.2% in 2024), driven by cost efficiency and dosing flexibility critical for clinical and home-based use. Herbalife Nutrition and Huel are prominent players in this area. The Prescription (Rx) channel is set to dominate distribution, projected to grow to 72% of the industry share in 2025 (from 68.5% in 2024), aligning with the broader integration of GLP-1 therapies into structured medical nutrition protocols and supported by physician oversight and reimbursement schemes. Fresenius Kabi, Baxter, and Nutricia are key players in the Rx segment.
Demographic Focus: The 35-54 Age Group as a Key Target
The 35-54 age group is emerging as a key target demographic, projected to reach a 33% share in 2025 (from 30.6% in 2024). This increase is driven by rising metabolic risk awareness and early-stage GLP-1 prescription trends, with claims data showing 56% of GLP-1 prescriptions in 2025 for patients in this bracket. Product launches targeting this group increased by over 21% year-on-year, with brands like Amway's Nutrilite and GNC optimizing offerings for midlife users seeking medically guided nutrition for weight loss and glycemic control.
Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-7580
Regional Growth Hotspots: Asia Leads the Charge
Global demand for GLP-1 nutritional support is rising at a 12.2% CAGR, with Asia-Pacific countries leading the charge. India is at the forefront with a projected 16.8% CAGR, outpacing the global rate by 4.6 points, driven by surging diabetic and pre-diabetic populations and expanding domestic supplement manufacturing. China follows closely at 15.4% CAGR, fueled by government-led metabolic health programs and expanding GLP-1 drug coverage. Germany posts a 12.7% CAGR, supported by insurance-backed nutrition trials. The United States trails at 11.2% CAGR, reflecting a prescription-heavy product reliance, while the United Kingdom shows a 10.9% CAGR, shaped by tighter labeling restrictions. These regional dynamics highlight diverse market drivers, from rapid urbanization and increasing disposable incomes in Asia to established healthcare infrastructures and reimbursement frameworks in OECD markets.
Competitive Landscape: Innovation and Strategic Partnerships
The GLP-1 nutritional support market is characterized by intense competition, with leading players leveraging clinical positioning, micronutrient optimization, and bariatric-friendly formats. Companies like Nestlé Health Science (e.g., www.glp-1nutrition.com launched in June 2024), Abbott, and Herbalife (e.g., MultiBurnTM introduced in July 2025) are developing nutrient-dense formulations focused on protein, B12, electrolytes, and appetite support, often bundled with telehealth or pharmacy programs. Unjury Protein and ProCare Health are prominent in bariatric and medical nutrition channels. Emerging brands like Replenza, Keptropy, and FullWell are tapping into direct-to-consumer channels, emphasizing glycemic control and lean mass preservation. Strategic partnerships and product innovation, such as Herbalife's GLP-1 Nutrition Companion launched in February 2024, are key to market positioning and growth, ensuring continuous advancements in tailored nutritional solutions for GLP-1 users.
Discover Related Research:-
Extended Release Drugs Market
https://www.futuremarketinsights.com/reports/extended-release-drugs-market
Ozempic Market
https://www.futuremarketinsights.com/reports/ozempic-market
GLP-1 Nutritional Support Market
https://www.futuremarketinsights.com/reports/glp-1-nutritional-support-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GLP-1 Nutritional Support Market to Skyrocket to USD 13 Billion by 2035, Driven by Metabolic Health Revolution here
News-ID: 4120275 • Views: …
More Releases from Future Market Insights Inc

Endoscopy Fluid Management Systems Market Poised for Significant Growth, Project …
The global Endoscopy Fluid Management Systems Market is on a trajectory of significant expansion, with a new market forecast projecting its value to more than double over the next decade. According to the latest analysis, the market, valued at an estimated USD 550.3 million in 2025, is expected to surge to USD 1,123.7 million by 2035. This robust growth represents a compound annual growth rate (CAGR) of 7.4% and is…

NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 …
A new market analysis projects the global Next-Generation Sequencing (NGS) Sample Preparation market to experience a significant surge, forecasting a valuation of USD 7.0 billion by 2035. This marks a substantial increase from its estimated USD 1.9 billion value in 2025, reflecting a robust Compound Annual Growth Rate (CAGR) of 13.7% over the decade. The findings underscore the pivotal role of sample preparation in the expanding field of genomics, driven…

Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Indus …
The global Eye and Face Protection Market is poised for significant expansion, with a new forecast predicting it will grow from an estimated USD 859.3 million in 2025 to USD 2,332.2 million by 2035. This robust growth trajectory represents a compound annual growth rate (CAGR) of 10.5% over the forecast period, driven by a confluence of rising industrial safety awareness, stringent regulatory mandates, and technological innovation.
Click Here for More Information:-…

Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, I …
The global market for dermatology excimer lasers is projected to surge from an estimated USD 109.7 million in 2025 to a remarkable USD 317.1 million by 2035, marking a significant compound annual growth rate (CAGR) of 11.2%. This substantial expansion is being fueled by a combination of factors, including the rising global prevalence of chronic skin conditions and a growing preference for advanced, targeted therapies.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/dermatology-excimer-lasers-market
Dermatology…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
[CAGR of 5.5%] Silica Flour Market Size, CAGR, Competitive Analysis and Forecast …
The global silica flour industry generated $520.0 million in 2021, and is estimated to reach $876.3 million by 2031, witnessing a CAGR of 5.5% from 2022 to 2031.
Allied Market Research published a report, titled, "Silica Flour Market by Type (Quartz, Cristobalite), by Application (Fiberglass, Glass and Clay, Oil Well Cement, Ceramic and Refractory, Foundry, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." The report offers a detailed analysis…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Call Center AI Market Latest, CAGR, Volume and Value 2022-2030 | (CAGR) of 25%
New York , United States- Report Ocean published the latest research report on the Call Center AI market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, business cycles, and microeconomic requirements that pertain precisely to the market under study. In addition, the Call Center AI market study demonstrates a detailed examination of the business state, which represents creative ways for company growth,…